Efficacy and safety of a once‐daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial

2010135 citationsJournal Article

Authors

EGb 761, 240 mg once-daily, was found significantly superior to placebo in the treatment of patients with dementia with neuropsychiatric symptoms.

Partnerships for the goals

Published in: International Journal of Geriatric Psychiatry

Volume 26, Issue 11, pp. 1186-1194

Field-Weighted Citation Impact: 25.81